This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

MINOCYCLINE HYDROCHLORIDE

Read time: 1 mins
Marketing start date: 30 Apr 2024

Summary of product characteristics


Adverse Reactions

Adverse Reactions

Contraindications

Contraindications

Description

Description

Dosage And Administration

Dosage and Administration

Warnings

Warnings

Overdosage

Overdosage

Clinical Pharmacology

Clinical Pharmacology

Effective Time

20230417

Version

7

Spl Product Data Elements

MINOCYCLINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE MINOCYCLINE MAGNESIUM STEARATE STARCH, CORN FERROSOFERRIC OXIDE SHELLAC GELATIN POTASSIUM HYDROXIDE TITANIUM DIOXIDE PROPYLENE GLYCOL gray opaque cap, white opaque body RX696

Animal Pharmacology And Or Toxicology

Animal Pharmacology and Toxicology

Application Number

ANDA065062

Brand Name

MINOCYCLINE HYDROCHLORIDE

Generic Name

MINOCYCLINE HYDROCHLORIDE

Product Ndc

61919-270

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

270

Spl Unclassified Section

SPL Unclassified Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride capsules, USP and other antibacterial drugs, minocycline hydrochloride capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Patient Medication Information

Patient Information

Precautions

Precautions

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.